RUBIC RESEARCH & DEVELOPMENT

RUBIC Research and Development takes the science from concept and drug discovery into a suitable, ethical, safe and cost-effective intervention. RUBIC brings together expertise from research where the science is discovered to development where the science is converted into a product to the commercialisation where a registered drug is taken to market. RUBIC’s South African Vaccine Economy (SAVE) initiative is the latest endeavour, catalysed by the COVID-19 pandemic. This initiative brings together expertise from the university, research, logistics and biotech sectors to find safe and effective, cost-effective, end to end vaccine solutions for Africa.